NDC 33342-003 – Lamivudine and Zidovudine

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC33342-003

Product details

Brand name
Lamivudine and Zidovudine
Generic name
Lamivudine and Zidovudine
Labeler
Macleods Pharmaceuticals Limited
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA090679
Marketed since
August 30, 2018
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (1)

Package NDCDescriptionSince
33342-003-0960 TABLET in 1 BOTTLE (33342-003-09)Aug 30, 2018

Other LAMIVUDINE and ZIDOVUDINE products